CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Active and Passive Vaccination for Pulmonary Arterial Hypertension: A Novel Therapeutic Paradigm Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study Optimal Strategy for Provisional Side Branch Intervention in Coronary Bifurcation Lesions: 3-Year Outcomes of the SMART-STRATEGY Randomized Trial Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials Double-Kiss-Crush Bifurcation Stenting: Step-by-Step Troubleshooting New Volumetric Analysis Method for Stent Expansion and its Correlation With Final Fractional Flow Reserve and Clinical Outcome An ILUMIEN I Substudy Histopathological validation of optical coherence tomography findings of the coronary arteries

Editorial2017 Dec 12;70(23):2875-2877.

JOURNAL:J Am Coll Cardiol. Article Link

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device?

King SB 3rd, Gogas BD. Keywords: bioresorbable vascular scaffold; prognosis; randomized trial; stent; technique; thrombosis

FULL TEXT PDF